Pharmacy Platform SmithRx Secures $60M in Series C Funding

The company aims to make getting prescriptions more accessible and affordable through pharmacy benefits.

Published on Jan. 24, 2024
Pharmacy Platform SmithRx Secures $60M in Series C Funding
An image depicting medication is shown.
Photo: Shutterstock

SmithRx, a pharmacy benefits manager, has raised $60 million in a Series C funding round led by Venrock. SmithRx is on a mission to transform the prescription medication management system. The company aims to make prescription medications more accessible, affordable and transparent for employers and individuals.

The company launched programs including autoimmune savings and low-cost insulin in 2023. It also formed partnerships with online pharmacies such as Mark Cuban Cost Plus Drug Company and Amazon Pharmacy. SmithRx plans to build on its recent momentum by enhancing its technology and further developing its pharmacy product with its new funding. 

Equipped with its fresh capital, SmithRx hopes to help usher in a new era in which patients, payers and providers are aligned to create a more equitable and efficient healthcare system.

This article was written by Writer, a generative AI tool, using information from press releases and company blogs provided by our staff. All content was reviewed by a Built In editor and went through a fact-checking process to ensure accuracy. Errors can be reported to our team at [email protected].

Hiring Now
Fitness • Hardware • Healthtech • Retail • Software